Showing 352 news articles about Resistance

Filters Content type: News Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Resistance

Lamivudine resistance mutation may persist for many years in some people with HIV

News
4 July 2024
Injectable & long-acting HIV treatment

Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern

News
8 May 2024
Injectable & long-acting HIV treatment

Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance

News
30 April 2024
Sexually transmitted infections prevention

Dissent on doxyPEP: recent guidelines becoming more cautious

News
26 April 2024
HIV treatment

Top 5 HIV treatment stories from CROI 2024

News
18 March 2024
Resistance

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?

News
12 March 2024
Resistance

New HIV drugs should be classed as inferior if they carry a higher risk of resistance

News
22 December 2023
Resistance

Dolutegravir resistance is rare, but some risk factors can up the odds

News
6 December 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023
Resistance

Resistance history does not affect response to dolutegravir / lamivudine

News
11 August 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
Injectable & long-acting HIV treatment

Rilpivirine resistance may be barrier to long-acting injectable treatment in South Africa

News
7 March 2023
Resistance

Failure of integrase inhibitor-based regimens may be due to a completely novel form of resistance

News
28 February 2023
Sexually transmitted infections prevention

Doxycycline PEP after sex appears ineffective for cisgender women

News
21 February 2023
Sexually transmitted infections prevention

No marked increase in gonorrhoea resistance in doxyPEP study

News
21 February 2023
Injectable & long-acting HIV treatment

‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months

News
1 November 2022
Resistance

Low-level HIV and viral load blips are important warning signals, European study finds

News
19 October 2022
Resistance

Are people with a shorter history of viral suppression at greater risk of failure of dolutegravir/lamivudine?

News
6 October 2022
Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

News
2 June 2022
HIV treatment for children & young people

High levels of infant resistance to abacavir and tenofovir in Namibia

News
6 May 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022
Injectable & long-acting PrEP

Injected PrEP: breakthrough cases could have been detected sooner

News
22 February 2022
HIV treatment for children & young people

Point-of-care viral load tests did not improve viral suppression in Kenyan children

News
16 February 2022